Geneva, Oct. 8 -- International Clinical Trials Registry received information related to the study (ACTRN12625001063404) titled 'Colchicine for coronary protection on dialysis (CCPD)' on Sept. 26.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Pharmacokinetics / pharmacodynamics
Primary Sponsor: Sydney Local Health District
Condition:
Chronic Kidney Disease
Haemodialysis
Cardiovascular Disease
Chronic Kidney Disease
Haemodialysis
Cardiovascular Disease
Renal and Urogenital - Kidney disease
Cardiovascular - Coronary heart disease
Intervention:
Participants will be given oral colchicine 0.25 mg three times per ...